Company Filing History:
Years Active: 2001
Title: Edward Unsworth: Innovator in Keratinocyte Growth Factor-2 Formulations
Introduction
Edward Unsworth is a notable inventor based in Kensington, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of formulations for therapeutic use.
Latest Patents
Unsworth holds a patent for Keratinocyte Growth Factor-2 formulations. This invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. The formulation of KGF-2 is intended for therapeutic use, specifically to promote or accelerate wound healing.
Career Highlights
Edward Unsworth has been associated with Human Genome Sciences, Inc., where he has applied his expertise in biotechnology. His work has focused on innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Reiner L Gentz and Arvind Chopra, who have collaborated with him on various projects within the company.
Conclusion
Edward Unsworth's contributions to the field of biotechnology, particularly through his patent on Keratinocyte Growth Factor-2 formulations, highlight his role as an innovator dedicated to advancing therapeutic solutions.